Yu et al., "Study on emm genotyping and drug-resistance gene of
group A Streptococcus pyogenes in Fengtai, Beijing (2011-2014)," Journal of Public Health and Preventive Medicine, vol.
More importantly, resistance to other antibiotics such as Macrolides is on the increase, which can be monitored only by regular testing of
Group A Streptococcus strains to such antibiotics.
(2009) Differences among
group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?
Overall, the OIA MAX test identified
group A streptococcus in 148 of the 363 (40.8%) patients, including 71 in group 1 (40.1%) and 77 in group 2 (41.4%).
StreptAvax(tm) is a multivalent recombinant vaccine developed to cover 26 serotypes of
group A streptococcus. According to data obtained from the Centers for Disease Control and Prevention (CDC), these serotypes are believed to be responsible for causing the vast majority of
group A streptococcus related diseases in North America.
An outbreak of surgical-wound infections due to
group A Streptococcus carried on the scalp.
With the support of the National Institute of Allergy and Infectious Diseases, scientists have determined the genetic sequence, or DNA code, for more than 95 percent of the
group A streptococcus organism.
Group A Streptococcus are reportedly Gram-positive bacteria, residing in the nose, throat and skin, while Group C and G Streptococcus (GCS and GGS, respectively) bacteria are less understood than Group A bacteria, although some strains of GCS and GGS have been increasingly reported to cause infections similar to those caused by GAS.
Group A Streptococcus are Gram-positive bacteria, found mainly in the nose, throat and skin, and responsible for a number of diseases, ranging from strep throat or skin infections to severe ones, such as necrotizing faciitis, or streptococcal toxic shock syndrome.
Similarly, surgical site infections with
Group A Streptococcus spp.